Royalty Report: Agriculture, Forestry and Fishing, Genome – Collection: 294265

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Agriculture
  • Forestry and Fishing
  • Genome
  • nucleic acid
  • Test/Monitoring
  • Medical
  • DNA
  • Drugs
  • Disease
  • Osteoarthritis
  • Autoimmune
  • obesity
  • Assay
  • Research

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 294265

License Grant
The parties will jointly develop a set of genomic markers associated with desired phenotypic traits in broilers in support of French Licensor’s continuing improvement in the breeding of Licensor’s pure lines for broilers.  The parties intend to work together toward developing these markers through the utilization of the discovery services, information, and data that are the subject of this Agreement and for Licensor’s commercialization of improved pure lines for broilers. Licensee will perform for Licensor the genomic discovery and development services as set forth in this Agreement, and Licensor will share with Licensee broiler phenotypic information, data and expertise as required for Licensee to perform the contemplated genomic services, all as set forth in this Agreement (which relationship, subject to the terms and conditions of this Agreement, shall be exclusive); and Licensor may use the markers to improve the breeding of its pure lines for broilers in order to respond to current and future needs of the poultry industry, and Licensee may commercialize the markers in fields not exploited by Licensor.
License Property
Joint Intellectual Property or Joint IP shall mean all results of the Research Plan that are identified, discovered, developed or invented through the use of both Licensor Technology and Licensee Technology, including all results of genotypes performed by Licensee on Samples, the data analyses performed by Licensee using the genotype results and phenotype, family or other information included in the Licensor Technology and the resulting statistics, and the Broiler Trait Associated SNP Set, the Production Trait Associated SNP Set. Notwithstanding the above, the Chicken Discovery Panel and any other intellectual property generated during Phase I or Phase II of the Research Plan shall be deemed not to be Joint Intellectual Property; all results obtained by Licensee using any phenotype or broiler identity data included in the Licensor Technology, including notably all the data and analysis results generated pursuant to Phases III, IV and V of the Research Plan, shall however be Joint Intellectual Property.

Licensor Technology shall mean all data (including the Licensor Materials and any other phenotype and broiler line data supplied by Licensor), information, inventions, know-how, technology, trade secrets, and the like, whether patentable or not, that are conceived, identified, discovered, developed, or invented in whole or part by or on behalf of Licensor independent of Licensee.

Licensee Technology shall mean (a) assay technology and all data, information, inventions, know-how, technology, trade secrets, and the like, whether patentable or not, including the Putative SNP Set, that are either (i) conceived, identified, discovered, developed, or invented in whole or part by or on behalf of Licensee independent of Licensor and without any use of Licensor Technology, whether as a part of the Research Plan or separately, and/or (ii) acquired or licensed by Licensee from Third Parties and (b) the Chicken Discovery Panel and any other intellectual property generated during Phase I or Phase II of the Research Plan.

Chicken Discovery Panel (which shall constitute Licensee Technology, not Joint IP) shall mean a subset of the Putative SNP Set, containing between 4000 and 8000 SNPs evenly spaced throughout the chicken genome, and validated by Licensee using Samples provided by Licensor as being an informative panel to use for the genome-wide association studies to be performed in Phases III and IV of the Research Plan.

Broiler Trait Associated SNP Set shall mean the collection of SNP markers from the Chicken Discovery Panel that are significantly associated with broiler traits of body weight, conformation score, feed conversion, meat yield, and livability discovered during Phase IV of the Research Plan, together with all associated data analyses and statistics, including those resulting from the validation analyses performed as Phase V of the Research Plan.

Genotype shall mean the specific nucleic acid sequence of an individual found at a specific location in the genome.

Genotyping shall mean the analysis of nucleic acid sequence variation at a specific location in the genome.

Production Associated SNP Set shall mean the collection of SNP markers from the Chicken Discovery Panel that are significantly associated with egg production discovered from Phase IV of the Research Plan, together with all associated data analyses and statistics, including those resulting from the validation analyses performed as Phase V of the Research Plan.

Putative SNP Set (which shall constitute Licensee Technology, not Joint IP) shall mean a set of at least 8000 (eight thousand) putative SNPs generated by Licensee without any use of Licensor Technology that cover the chicken genome, have known, unique locations on the public chicken genome assembly and are evenly dispersed throughout the chicken genome.

Samples shall mean the blood samples collected by Licensor from the various populations of chickens studied in the Research Plan and delivered to Licensee as described in the Research Plan.

Field of Use
Field shall mean the use of genomic markers to detect and/or manage targeted traits in broiler livestock.

IPSCIO Record ID: 298787

License Grant
The parties will jointly develop a set of genomic markers associated with desired phenotypic traits in broilers in support of French Licensee’s continuing improvement in the breeding of Licensee’s pure lines for broilers.  The parties intend to work together toward developing these markers through the utilization of the discovery services, information, and data that are the subject of this Agreement and for Licensee’s commercialization of improved pure lines for broilers. Licensor will perform for Licensee the genomic discovery and development services as set forth in this Agreement, and Licensee will share with Licensor broiler phenotypic information, data and expertise as required for Licensor to perform the contemplated genomic services, all as set forth in this Agreement (which relationship, subject to the terms and conditions of this Agreement, shall be exclusive); and Licensee may use the markers to improve the breeding of its pure lines for broilers in order to respond to current and future needs of the poultry industry, and Licensor may commercialize the markers in fields not exploited by Licensee.
License Property
Joint Intellectual Property or Joint IP shall mean all results of the Research Plan that are identified, discovered, developed or invented through the use of both Licensee Technology and Licensor Technology, including all results of genotypes performed by Licensor on Samples, the data analyses performed by Licensor using the genotype results and phenotype, family or other information included in the Licensee Technology and the resulting statistics, and the Broiler Trait Associated SNP Set, the Production Trait Associated SNP Set. Notwithstanding the above, the Chicken Discovery Panel and any other intellectual property generated during Phase I or Phase II of the Research Plan shall be deemed not to be Joint Intellectual Property; all results obtained by Licensor using any phenotype or broiler identity data included in the Licensee Technology, including notably all the data and analysis results generated pursuant to Phases III, IV and V of the Research Plan, shall however be Joint Intellectual Property.

Licensee Technology shall mean all data (including the Licensee Materials and any other phenotype and broiler line data supplied by Licensee), information, inventions, know-how, technology, trade secrets, and the like, whether patentable or not, that are conceived, identified, discovered, developed, or invented in whole or part by or on behalf of Licensee independent of Licensor.

Licensor Technology shall mean (a) assay technology and all data, information, inventions, know-how, technology, trade secrets, and the like, whether patentable or not, including the Putative SNP Set, that are either (i) conceived, identified, discovered, developed, or invented in whole or part by or on behalf of Licensor independent of Licensee and without any use of Licensee Technology, whether as a part of the Research Plan or separately, and/or (ii) acquired or licensed by Licensor from Third Parties and (b) the Chicken Discovery Panel and any other intellectual property generated during Phase I or Phase II of the Research Plan.

Chicken Discovery Panel (which shall constitute Licensor Technology, not Joint IP) shall mean a subset of the Putative SNP Set, containing between 4000 and 8000 SNPs evenly spaced throughout the chicken genome, and validated by Licensor using Samples provided by Licensee as being an informative panel to use for the genome-wide association studies to be performed in Phases III and IV of the Research Plan.

Broiler Trait Associated SNP Set shall mean the collection of SNP markers from the Chicken Discovery Panel that are significantly associated with broiler traits of body weight, conformation score, feed conversion, meat yield, and livability discovered during Phase IV of the Research Plan, together with all associated data analyses and statistics, including those resulting from the validation analyses performed as Phase V of the Research Plan.

Genotype shall mean the specific nucleic acid sequence of an individual found at a specific location in the genome.

Genotyping shall mean the analysis of nucleic acid sequence variation at a specific location in the genome.

Production Associated SNP Set shall mean the collection of SNP markers from the Chicken Discovery Panel that are significantly associated with egg production discovered from Phase IV of the Research Plan, together with all associated data analyses and statistics, including those resulting from the validation analyses performed as Phase V of the Research Plan.

Putative SNP Set (which shall constitute Licensor Technology, not Joint IP) shall mean a set of at least 8000 (eight thousand) putative SNPs generated by Licensor without any use of Licensee Technology that cover the chicken genome, have known, unique locations on the public chicken genome assembly and are evenly dispersed throughout the chicken genome.

Samples shall mean the blood samples collected by Licensee from the various populations of chickens studied in the Research Plan and delivered to Licensor as described in the Research Plan.

Field of Use
Field shall mean the use of genomic markers to detect and/or manage targeted traits in broiler livestock.

IPSCIO Record ID: 290206

License Grant
The objective of this Agreement is to jointly develop genomic DNA-based diagnostic products (the Products) to detect the Targeted Traits in bovine animals in respect to meat production or processing in the animal production and meat  processing industries with the goal of jointly commercializing such Products for sale, following the Licensee Period of Exclusivity, to potential buyers in these industries initially in North America and, ultimately worldwide.
License Property
Targeted Traits shall mean the traits of marbling, tenderness, red meat yield, and average daily gain.

Licensor Technology shall mean assay technology and all data, information, inventions, know-how, technology, trade secrets and the like, whether patentable or not, that are (a) conceived, identified, discovered, developed, or invented in whole or part-by or on behalf of Licensor independent of The Licensee Entities and independent of The Licensee Entities material and/or The Licensee Entities Technology,  including the Putative SNP Set and/or (b) acquired or licensed by Licensor from Third Parties.

Joint Intellectual Property or Joint IP shall mean any technology, data, information, inventions, know-how, trade secrets, and the like, whether patentable or not, that are conceived, identified, discovered, developed, or invented by the Parties or any of them pursuant to any of the activities conducted pursuant to the Work Plan.  Joint IP shall include all the Deliverables described in the Work Plan, including but not limited to the Validated SNP Set (as defined in the Work Plan), the Associated SNP Sets, the Diagnostic SNP Sets for each of the Targeted Traits, all Datasets, all information contained in any reports issued by Licensor under the Work Plan, the results and data of the association studies, and any trait-specific assay that individually or in combination, detects the Targeted Traits.

Genotype shall mean the specific nucleic acid sequence of an individual found at a specific location in the genome.

Genotyping shall mean the analysis of nucleic acid sequence variation at a specific location in the genome.

Licensor has developed and licensed in resources and expertise in the areas of on-line information, discovery sciences, discovery services, and agricultural products that are based on Licensors  generation, integration, and analysis of biological information and that enable agricultural research and discoveries by the members of the agriculture industry and research community.

Field of Use
Licensor will identify markers to predict traits like meat quality and weight gain in the animal.  Tools could identify cattle that meet consumer demands for quality meat products.

Licensee is engaged in the business of processing cattle and other livestock into various meat and animal-derived  products, and the sale of such products.

IPSCIO Record ID: 289185

License Grant
The objective of this Agreement is to jointly develop genomic DNA-based diagnostic products (the Products) to detect the Targeted Traits in bovine animals in respect to meat production or processing in the animal production and meat  processing industries with the goal of jointly commercializing such Products for sale, following the Licensor Period of Exclusivity, to potential buyers in these industries initially in North America and, ultimately worldwide.
License Property
Licensor is engaged in the business of processing cattle and other livestock into various meat and animal-derived  products, and the sale of such products.

Targeted Traits shall mean the traits of marbling, tenderness, red meat yield, and average daily gain.

Licensee Technology shall mean assay technology and all data, information, inventions, know-how, technology, trade secrets and the like, whether patentable or not, that are (a) conceived, identified, discovered, developed, or invented in whole or part-by or on behalf of Licensee independent of The Licensee Entities and independent of The Licensee Entities material and/or The Licensee Entities Technology, including the Putative SNP Set and/or (b) acquired or licensed by Licensee from Third Parties.

Joint Intellectual Property or Joint IP shall mean any technology, data, information, inventions, know-how, trade secrets, and the like, whether patentable or not, that are conceived, identified, discovered, developed, or invented by the Parties or any of them pursuant to any of the activities conducted pursuant to the Work Plan.  Joint IP shall include all the Deliverables described in the Work Plan, including but not limited to the Validated SNP Set (as defined in the Work Plan), the Associated SNP Sets, the Diagnostic SNP Sets for each of the Targeted Traits, all Datasets, all information contained in any reports issued by Licensee under the Work Plan, the results and data of the association studies, and any trait-specific assay that individually or in combination, detects the Targeted Traits.

Genotype shall mean the specific nucleic acid sequence of an individual found at a specific location in the genome.

Genotyping shall mean the analysis of nucleic acid sequence variation at a specific location in the genome.

Field of Use
Under the terms of the agreement, the parties agreed to jointly develop and commercialize products for the cattle industry intended to be predictive of traits that improve production economics or meet consumer demands for quality, consistency and tenderness.

Licensee has developed and licensed in resources and expertise in the areas of on-line information, discovery sciences, discovery services, and agricultural products that are based on Licensees generation, integration, and analysis of biological information and that enable agricultural research and discoveries by the members of the agriculture industry and research community.

IPSCIO Record ID: 211838

License Grant
Licensor, a non-profit biomedical research institution, grants to the Australian Licensee an exclusive, permanent, worldwide license to use the Project Intellectual Property for the purpose of developing and commercially exploiting the results of the Project and Licensee shall have the right to sub-license its rights and to decide in its absolute discretion as to how the Intellectual Property and the Products are to be commercially exploited.
License Property
The licensed property relates to Gene Discovery for Diabetes/Obesity in Human Families.

1) Establishment of Autogen Center for Statistical Genomics including dedicated computing resources.
In order to meet the needs of Autogen’s Human Genomics program, a computer cluster comprising 300 processors (described in the Budget in Item 2 of Schedule 1) will be added to the extant processor cluster at SFBR. While it will be completely integrated into the larger computer system (and thus benefit from an existing administrative structure), these processors will be available as required for Autogen statistical genomics research. These computers will be placed in the new SBC Genomics Computing Center building (projected opening date February 14, 2003).

2) Analysis of 4 ISR Candidate Genes for Diabetes/Obesity in Human Populations.
In order to conclusively test for the effects of variation in Autogen proprietary genes on diabetes/obesity related phenotypes in humans, we will perform an exhaustive series of statistical genomic analyses on human samples. The possible sample sources (to be negotiated independently of this document) for these studies include (but are not limited to) the Wisconsin families from the MRCOB study, Mexican American families from the San Antonio Family Heart Study, and Autogen’s extant samples from Pacific Island populations.
Tasks
a) Genotype cleaning Mendelian error checking, elimination of double recombinants. This task is limited to family-based samples.
b) Haplotype inference and genotype imputation.
c) Quantitative trait nucleotide analysis using the Bayesian model selection/model averaging approach.
d) Conditional linkage analysis to test whether best SNP Gene Action model accounts for linkage. This task is limited to family-based samples.
These analyses will allow us to determine whether or not variants in a given gene appear to have functional effects on relevant human phenotypes and whether or not the gene completely identifies the underlying human QTL. Final analyses will include estimates of the posterior probability that a given variant has functional effects for each DNA variant examined.

3) Gene Discovery for Diabetes/Obesity in Human Families
This aim launches a gene discovery research program based around samples from human families. We plan to take existing well defined and localized QTLs and attempt identification of novel genes in the original family material. It is anticipated (although not mandatory) that these analyses will be performed on samples from current Autogen collaborations (including the MRCOB Wisconsin family study or the San Antonio Family Heart Study).
Tasks
a) Additional STR genotype cleaning and map integration. It is anticipated that approximately 5 additional markers will be analyzed per QTL region.
b) Identity-by-descent probability calculation for region including new STRs.
c) Quantitative trait linkage analysis using the additional STRs to refine localization interval.
d) Strategy 1 Focal positional candidate gene approach. For SNPs within positional candidate genes chosen via bioinformatic methods, a similar set of tasks to those described in Aim 2 will be performed. These will include genotype cleaning, haplotype inference and genotype imputation, quantitative trait nucleotide analysis, and conditional linkage analysis to verify QTL dissection. The total time per QTL (assuming 3 genes will be analyzed exhaustively) is 48 weeks.
e) Strategy 2 Positional candidate region approach without obvious candidate genes. For QTL regions, which lack obvious positional candidate genes, a general SNP coverage strategy will be pursued.  Specific analytical tasks to be performed include analysis of linkage disequilibrium followed by optimal choice of independent SNPs; preliminary association analysis of 200 individuals for 5 SNPs per gene for 30 genes; SNP analyses within families including genotype cleaning, haplotype inference and genotype imputation, QTN analysis and conditional linkage analysis per gene = 2 weeks. The total time per QTL (assuming 2 genes ultimately will be analyzed exhaustively) is 48 weeks.

Field of Use
The Research Fields means the fields of diabetes, obesity, osteoporosis, depression, allergy, asthma and autoimmunity and such other fields as may be included by mutual written agreement.

IPSCIO Record ID: 291929

License Grant
Licensor hereby grants Licensee a, worldwide, non-transferable, non-exclusive license under Licensor Licensed Technology, to, (1) develop Generic Kits and Standard Kits as authorized in this Agreement, (2) make, have made, and use (which use includes the right to modify) Licensor OEM Kits and (3) distribute, market and sell such Licensor OEM Kits (OEM License) pursuant to the license granted to Licensee as set forth in this Agreement. Licensee agrees to forbear from the use and exercise of the OEM License otherwise a royalty payment will be due.  If Licensee grants any Third Party a license to exploit the TAG Improvements, Licensee shall pay Licensor a royalty.

The purpose of the Collaboration is to develop, manufacture, market and sell (i) Products, and (ii) software applications for Approved Instruments all as set forth in this agreement. The purpose of the Collaboration may be modified and/or extended upon mutual agreement of the Parties in writing.

License Property
Licensor Licensed Technology means Technology Controlled by Licensor and its Affiliates as of the Effective Date that is useful in the Field of Use, as listed or described hereto. Licensor represents and warrants that the items listed hereto comprise all of the Licensor Licensed Technology as of the Effective Date of this agreement. As of the Effective Date the Licensor Licensed Technology does not require payment of royalties to third parties. Licensor and its Affiliates will amend this from time to time to keep it current. Licensor and its Affiliates warrant that all Controlled Technology for carrying out the marketing, sale, and other disposition of Products will be included in the Licensor Licensed Technology.

US Patent 5,888,819 – Method for determining nucleotide identity through primer extension

Product means any of a Standard Kit, a Custom Kit and/or a Generic Kit.

Combination Kit means any Custom Kit that contains Primers more than 50% of which are identical to Primers contained in any part of any Standard Kits existing at the time of launch of such Custom Kit, or any combination of Standard Kits existing at the time of launch of such Custom Kit.

Custom Kit means a kit consisting of certain Reagents, certain Primers that have been customized by Licensor or Licensors subcontractors for use in the Field of Use and an End User License, and shall not include use of or refer to any use of TAG Arrays other than for genotyping with GBA.

Standard Kit means a kit consisting of Reagents, CMC Approved Primers for use in the Field of Use and an End User License.

Generic Kit means a kit consisting of Reagents and an End User License.

Primer means GBA primers (a synthetic oligonucleotide of a sequence known to be complementary with the oligonucleotide sequence immediately adjacent, 5, to a SNP) or either PCR primers or information to generate PCR primers.

Reagent means buffers, enzymes and terminators (but not Primers) useful in GBA.

GBA means Genetic Bit Analysis, or single nucleotide primer extension methods designed to detect the identity of a single nucleotide at a predetermined location in the DNA of a sample.

SNP means Single Nucleotide Polymorphism.

Technology means and includes all inventions, discoveries, improvements, trade secrets and proprietary methods and materials, whether or not patentable, including but not limited to, samples of, methods of production or use of, and structural and functional information pertaining to, chemical compounds, proteins or other biological substances; other data; formulations; techniques; and know-how; including any negative results.

TAG Array means a tag array GeneChip probe array. Each set of probes consists of four probes with the following relationship to a defined target sequence — a perfect match to target sequence, a single base mismatch to target sequence, a perfect match to the complement of target sequence, and, a single base mismatch to the complement of target sequence. For the avoidance of doubt, TAG Arrays include no license (express or implied) authorizing use for any purpose except genotyping with GBA.

TAG Assay means any assays for hybridization to a TAG Array.

TAG improvement is any improvements to TAG Assays.

Field of Use
These new assays will allow researchers to customize high density SNP analyses solely by designing GBA primers for use on a standard GeneChip array.

The first products to be commercialized by the alliance will include reagent kits for use with Licensee's new universal array designed to perform thousands of user-defined SNP analyses.  Licensee has developed and intends to establish its GeneChip® system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease.

Field of Use means the use of Product to practice GBA in Tag Array format in Approved Instruments for Research Purposes and clinical reference laboratories where work is performed under the Clinical Laboratory Improvements Act and explicitly excludes Products that have received marketing approval from the FDA.

GeneChip system is a commercial microarray platform that allows whole genome gene expression analysis for a wide variety of experimental organisms.

IPSCIO Record ID: 203441

License Grant
Licensor agrees to assign to Licensee the Licensors right, title and interest to the Licensee DNA Information developed by Licensor and DNA Patent Rights.

Licensor grants a non-exclusive, worldwide license for internal use only,  for the Analytical Technology, developed by either party, following a material contribution to the development thereof by Licensee. This license includes Licensees right to use such Analytical Technology to develop, make, have made, import, use, sell, have sold, and offer to sell Licensed Products and in connection with a bona fide scientific collaboration between Licensee and a third party under a written contract and research plan in a specific area. This license does not include Licensees right to transfer, sell, or license such Analytical Technology.

License Property
Technology  refers to a cutting edge informational genomics technologies to the development of better crops.

Analytical Technology shall mean algorithms and other analytical techniques and methods, including, without limitation, methods of generating, storing, retrieving and analyzing data developed in the course of carrying out the Project Plan.

Analytical Patent Rights shall mean inventions related to Analytical Technology developed by or for Licensee carrying out the Project Plan expressly excluding inventions related to DNA sequences or oligonucleotide probe sequences, array designs, array data and the results of analysis of such array data.

Licensed Products shall mean a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making, modifying or modulating any of the foregoing or any phenotypic trait associated with any of the foregoing, which, in the absence of a license, would infringe at least one (1) claim of an unexpired U.S. or foreign patent or one (1) pending claim of an unexpired published patent application included within DNA Patent Rights which claims a Gene Lead.

Gene Lead shall mean any gene identified by Licensor in connection with its analysis of Licensee DNA Information and which has been determined to be a Gene Lead. Each Gene Lead shall be included in Licensee DNA Information.

Field of Use
This agreement specifically relates to maize and rice and tissue-specific oligonucleotides.

The parties research alliance is for creating proprietary intellectual property relating to the design, development and use of microarrays, the design, development and application of gene expression databases and the identification of genes predictive of traits.

IPSCIO Record ID: 282956

License Grant
Licensor hereby grants to Licensee under the Licensed Patents a non-exclusive license, without the right to grant sublicenses, to make, sell, offer for sale or otherwise dispose of Licensed Products in the Territory solely for use in the Licensed Field. Under this license, Licensee may use the Licensed Products only to the extent necessary for Licensee to perform quality control functions on lots of the Licensed Products, but under no circumstances may Licensee use the Licensed Products for Research Purposes or for any other purpose within or outside the License Field.
License Property
Licensed Product means a Kit and an End User License.

Licensed Patents means US Patent No. 5,888,819 and 6,004,744 and any divisionals, continuations, reissues, and foreign counterparts thereof.

5,888,819 – Method for determining nucleotide identity through primer extension
6,004,744 – Method for determining nucleotide identity through extension of immobilized primer

Instruments' mean automated electrophoresis nucleotide sequencing

'Genotype' means the detection or quantification of an individual SNP within a single sample (whether or not the genome of the sample is heterozygous for the given SNP).

Kit means a product designed for performing Primer Extension comprising one or more Reagents, the sale or offer for sale of which, without the licenses granted herein, would infringe or contribute to the infringement of at least one claim of a Licensed Patent.

Primer Extension means a nucleic acid template-dependent primer extension reaction to determine the identity of a single nucleotide base at a specific position in a nucleic acid of interest in which the reaction is performed in the presence of two or more terminators and in the absence of extendable nucleotides.

Reagent means an enzyme, buffer, primer extension chain-terminating compound or other composition useful for Primer Extension.

Field of Use
Licensed Field means the use of a Licensed Product on Approved Instruments for Research Purposes only. Practical applications of these techniques include genetic disease diagnoses, infectious disease diagnoses, forensic techniques, paternity determinations, and genome mapping.

IPSCIO Record ID: 223436

License Grant
Licensor agrees to assign to Licensee the Licensors right, title and interest to the Licensee DNA Information developed by Licensor and DNA Patent Rights.

Licensor grants a non-exclusive, worldwide license for internal use only,  for the Analytical Technology, developed by either party, following a material contribution to the development thereof by Licensee. This license includes Licensees right to use such Analytical Technology to develop, make, have made, import, use, sell, have sold, and offer to sell Licensed Products and in connection with a bona fide scientific collaboration between Licensee and a third party under a written contract and research plan in a specific area. This license does not include Licensees right to transfer, sell, or license such Analytical Technology.

License Property
Analytical Technology shall mean algorithms and other analytical techniques and methods, including, without limitation, methods of generating, storing, retrieving and analyzing data developed in the course of carrying out the Project Plan.

Analytical Patent Rights shall mean inventions related to Analytical Technology developed by or for Licensee carrying out the Project Plan expressly excluding inventions related to DNA sequences or oligonucleotide probe sequences, array designs, array data and the results of analysis of such array data.

Licensed Products shall mean a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making, modifying or modulating any of the foregoing or any phenotypic trait associated with any of the foregoing, which, in the absence of a license, would infringe at least one (1) claim of an unexpired U.S. or foreign patent or one (1) pending claim of an unexpired published patent application included within DNA Patent Rights which claims a Gene Lead.

Predictive Pattern Technology shall mean a particular product, not including plant or animal, plant or animal parts, animal progeny, used to predict characteristics.

DNA Patent Rights shall mean inventions utilizing Licensee DNA Information developed by or for Licensor in the course of carrying out the Project Plan.

Gene Lead shall mean any gene identified by Licensor in connection with its analysis of Licensee DNA Information and which has been determined to be a Gene Lead. Each Gene Lead shall be included in Licensee DNA Information.

This agreement specifically relates to maize and rice and tissue-specific oligonucleotides.

Field of Use
The parties research alliance is for creating proprietary intellectual property relating to the design, development and use of microarrays, the design, development and application of gene expression databases and the identification of genes predictive of traits.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.